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Abstract
Melancholic depression is a biologically homogeneous clinical entity in which structural brain alterations have been
described. Interestingly, reports of structural alterations in melancholia include volume increases in Cerebro-Spinal Fluid
(CSF) spaces. However, there are no previous reports of CSF volume alterations using automated whole-brain voxel-wise
approaches, as tissue classification algorithms have been traditionally regarded as less reliable for CSF segmentation. Here
we aimed to assess CSF volumetric alterations in melancholic depression and their clinical correlates by means of a novel
segmentation algorithm (‘new segment’, as implemented in the software Statistical Parametric Mapping-SPM8),
incorporating specific features that may improve CSF segmentation. A three-dimensional Magnetic Resonance Image
(MRI) was obtained from seventy patients with melancholic depression and forty healthy control subjects. Although
imaging data were pre-processed with the ‘new segment’ algorithm, in order to obtain a comparison with previous
segmentation approaches, tissue segmentation was also performed with the ‘unified segmentation’ approach. Melancholic
patients showed a CSF volume increase in the region of the left Sylvian fissure, and a CSF volume decrease in the
subarachnoid spaces surrounding medial and lateral parietal cortices. Furthermore, CSF increases in the left Sylvian fissure
were negatively correlated with the reduction percentage of depressive symptoms at discharge. None of these results were
replicated with the ‘unified segmentation’ approach. By contrast, between-group differences in the left Sylvian fissure were
replicated with a non-automated quantification of the CSF content of this region. Left Sylvian fissure alterations reported
here are in agreement with previous findings from non-automated CSF assessments, and also with other reports of gray and
white matter insular alterations in depressive samples using automated approaches. The reliable characterization of CSF
alterations may help in the comprehensive characterization of brain structural abnormalities in psychiatric samples and in
the development of etiopathogenic hypotheses relating to the disorders.
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Introduction
Melancholic depression is a subtype of major depressive
disorder (MDD) that encompasses a constellation of distinctive
clinical features such as anhedonia, distinct quality of mood and
mood non-reactivity, psychomotor disturbances, feelings of guilt,
early awakening, diurnal variation and anorexia [1–4]. Specific
neurobiological correlates such as cortisol dysregulation and
altered sleep patterns have also been appreciated in melancholia
[5–7]. Indeed, since all these symptoms are regularly present in
most melancholic patients, melancholia may be considered as
a biologically homogeneous clinical entity, especially when
compared with other depression subtypes [2,8].
In addition to such features, a number of studies have also
identified brain structural alterations in melancholia [9–15], such
as volume reductions in the hippocampus [9], right anterior
supplementary motor area [14] or left insula [15]. Interestingly, in
a subset of these studies [10–12], alterations in cerebro-spinal fluid
(CSF) spaces were also described. Thus, using Region-of-Interest
(ROI) approaches, early reports from our group, and other groups,
showed volumetric enlargements of the CSF spaces surrounding
the upper frontal lobe [12] and the left Sylvian fissure [10,11].
Furthermore, in one of the studies [10], CSF increases in the left
Sylvian fissure were related to the time to remission of the
depressive episode, thus giving clinical relevance to the findings.
Voxel-wise methods such as voxel based morphometry (VBM)
[16] are particularly appropriate for the study of brain structural
alterations as they offer an unbiased estimation of whole-brain
abnormalities [17]. However, since VBM strongly depends on
accurate brain tissue segmentation [17], CSF alterations have
rarely been assessed using such procedures as CSF segmentation
has traditionally been regarded as a rather unreliable approach.
Indeed, although in most segmentation algorithms CSF is
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accurately isolated from gray and white matter, it is not
uncommon for segmented CSF images to include voxels from
non-brain structures such as the dura, the venous sinuses, the scalp
or the skull. Consequently, until now we have not attempted to
directly replicate with a voxel-wise technique the CSF findings
previously described in melancholic samples using ROI ap-
proaches.
Nevertheless, the development of new tissue segmentation
algorithms, such as the so-called ‘new segment’ algorithm [18]
(included in the last version of the Statistical Parametric Mapping
software, SPM8 [19]), may help to overcome such limitations, as it
provides further information as to the a priori distribution of non-
brain tissue. The new algorithm should prevent misclassification of
non-brain voxels as CSF [18]. The aim of this study was to assess
whole-brain voxel-wise alterations in the CSF spaces of a sample of
melancholic patients in comparison to a group of control subjects
of similar age and gender distribution. To evaluate the benefits of
using the ‘new segment’ algorithm, we compared the results
obtained using such a method with those obtained by means of the
‘unified segmentation’ approach [20], as implemented in both
SPM5 and SPM8. In addition, the most relevant between-group
differences observed with the ‘new segment’ algorithm were
validated by means of a non-automated ROI analysis. Finally, to
evaluate the relevance of CSF alterations, findings were correlated
with the clinical data of the study sample.
Methods
Ethics Statement
The study protocol was approved by the ethical committee of
clinical research (CEIC) of the Bellvitge University Hospital, and
was in compliance with the national legislation and the principles
expressed in the Declaration of Helsinki. All participants gave
written informed consent after detailed description of the study.
Subjects
A total of 70 inpatients (41 women, mean age 6
SD=61.5669.68) with melancholic depression were consecutively
recruited from the Mood Disorders Unit of the Bellvitge
University Hospital, Barcelona. Sample characteristics are shown
in Table 1 and have been reported elsewhere [15]. Patients
included in the study met criteria for a current major depressive
episode with melancholic features according to DSM IV-TR
criteria [1]. Diagnosis was independently confirmed by two senior
psychiatrists (M.U. and N.C.) using the Structured Clinical
Interview for DSM IV-TR Axis I Disorders–Clinician Version
[21]. MDD severity was assessed by means of the Hamilton Rating
Scale for Depression-17 items [22] (HAM-D), in which all patients
scored between moderate and severe depressive episodes (HAM-D
range between 18 and 51 points). The control group was made up
of 40 subjects (23 women, mean age 6 SD=59.2367.09) of
similar age and gender distribution and from the same socio-
demographic environment.
A detailed medical history was recorded and a structured
interview was administered to detect subjects who fulfilled exclusion
criteria. For both groups, exclusion criteria included the presence or
past history of any Axis I or Axis II diagnosis (excepting MDD in
patients), the presence or past history of neurologic or other serious
medical conditions (including dementia), any contraindication to
MRI scanning, or abnormal MRI upon visual inspection. Specif-
ically, to ensure there were no cases of cardiovascular etiology, any
evidence of ischemic tissue damage in the MRI was regarded as an
exclusion criterion. However, subjects with controlled hypertension
or diabetes mellitus Type 2 (DM-II) were not excluded (27.59% of
the patients and 32.43% of the healthy controls did have either one
or both conditions). All patients were clinically followed up for at
least two years through contact with the Mood Disorders Unit.
During this period, the presence of emerging signs of dementia was
ruled out by the routine clinical interview, which included the
administration of the Mini-Mental State Examination (MMSE,
[23]).
MRI Acquisition
Subjects were scanned in a 1.5-T scanner (Signa, GE Medical
Systems, Milwaukee, WI) to obtain a sixty-slice 3-D SPGR
sequence in the axial plane (TR 40 ms, TE 4 ms, pulse angle 30u,
field of view 26 cm, matrix size 2566192 pixels, in-plane
resolution 1.02 mm2, and section thickness 2.5 mm). Imaging
data were processed on a Microsoft Windows platform using
technical computing software (MATLAB 7.8; The MathWorks
Inc, Natick, Mass) and Statistical Parametric Mapping (SPM8;
The Wellcome Department of Imaging Neuroscience, London,
UK) [19].
Data Preprocessing
Firstly, images were inspected for the presence of any artifacts
preventing further analyses. Preprocessing involved three main
steps; tissue segmentation, normalization, and smoothing, which
are described below. We used two different segmentation
algorithms, but in all cases images were normalized using
DARTEL tools [24] and smoothed with an 8 mm full-width at
half maximum (FWHM) isotropic Gaussian kernel.
Segmentation. Images were segmented in parallel using two
different algorithms: the ‘unified segmentation’, as implemented in
SPM5 and SPM8 [20], and the ‘new segment’, as implemented in
SPM8 [18].
On the one hand, the ‘unified segmentation’ algorithm extracts
three tissue classes (gray matter, white matter and CSF) from raw
T1 images using a probabilistic framework combining tissue
classification, image registration and bias correction. For the
purpose of this study, from this step we discarded final output
images in normalized space, exclusively keeping files that encoded
the segmentation and normalization transformations applied to
raw data (the *_seg_sn.mat files). These files were used as an
‘initial import’ in DARTEL tools in order to write out rigidly
transformed versions of CSF tissue (rc3*.nii files), which were
saved for the subsequent normalization process.
On the other hand, the ‘new segment’ algorithm is an extension
of the ‘unified segmentation’ algorithm that uses an extended set of
tissue probability maps allowing for a different treatment of voxels
outside the brain (i.e., the ones most likely to be classified as CSF).
In addition to gray matter, white matter and CSF tissue
probability maps, this algorithm incorporates tissue probability
maps of bone, soft tissue and air/background distribution. The
‘new segment’ algorithm also segments, normalizes and corrects
bias within the same model, and, also as above, we discarded final
output images from this preprocessing and kept the rigidly
transformed versions of CSF images that were used for DARTEL
normalization (rc3*.nii files).
Normalization and smoothing. The rigidly transformed
images of CSF derived from both the ‘unified segmentation’ and
the ‘new segment’ algorithms were normalized using DARTEL
[24]. Firstly, with the function ‘create templates’, images were
iteratively matched to a template generated from their own mean,
so as to generate a series of templates with increasing resolution.
Secondly, native space images from CSF were registered to the
highest resolution CSF template within a high-dimensional
diffeomorphic framework. Spatially normalized tissue maps were
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then modulated by the Jacobian determinants derived from the
corresponding flow-fields to restore the volumetric information lost
during the high-dimensional spatial registration.
Finally, bias corrected, tissue segmented, and DARTEL
normalized and modulated CSF images were smoothed with an
8 mm FWHM isotropic Gaussian kernel.
Data Analysis
Global CSF and total intracranial volume (TIV), obtained from
segmented images in native space, were compared between groups
by means of independent samples t-tests using SPSS (v. 15).
Between-group comparisons of voxel-wise regional volume
differences were studied with SPM8 tools. Specifically, two
independent sample t-test models (i.e. one for images derived
from the ‘unified segmentation’ and one for the images derived
from the ‘new segment’ algorithm) were built, with TIV as
a nuisance covariate.
Subsequently, in a post-hoc analysis, between-group differences
in CSF volume observed in the region of the left Sylvian fissure
(see Results section, below) were validated with a non-automated
ROI analysis. Specifically, the region was bilaterally traced by one
researcher (I.M.Z.), who was blind to subjects’ diagnosis and
hemisphere, on 25 consecutive axial slices of the raw T1 image
from each participant using MRIcro software [25]. For each
hemisphere, we extracted the volume of the ROI (in milliliters)
and the mean signal value across the ROI (normalized to global
signal intensity and ROI volume). These two measurements
contribute to the final voxel values in images used for VBM
analyses, since image segmentation relies on raw signal intensity
and modulation restores the volumetric information lost after
spatial normalization to a template. Data from each hemisphere
were entered into SPSS and analyzed by means of independent
samples t-tests.
Finally, to study the correlation between CSF alterations and
clinical data, we firstly extracted the first eigenvariate from clusters
with significant between-group differences. The values were
entered into SPSS and correlated (controlling for total intracranial
volume) with the number of previous depressive episodes, time to
remission of the current episode, HAM-D score at admission and
percentage of HAM-D reduction between admission and dis-
charge.
In all the SPM analyses, the significance threshold was set at
p,0.05 (family-wise error [FWE] corrected for multiple compar-
isons), although, for displaying purposes (i.e., figures), we used
a threshold of p,0.001 (uncorrected). In SPSS analyses, the
significance threshold was set at p,0.05 with the applicable
Bonferroni correction when multiple independent analyses were
performed (i.e., in correlations between imaging findings and
clinical data).
Results
Global CSF and Total Intracranial Volumes
Regarding global CSF volume, no significant between-group
differences were observed when images were segmented using the
‘new segment’ approach. Nevertheless, a significant global CSF
volume increase in melancholic patients was observed when
images were segmented using the ‘unified segmentation’ algo-
rithm. By contrast, significant between-group differences in TIV
were not observed with either segmentation approach. These
results are presented in Table 2.
Voxel-wise CSF Assessment
Using the ‘new segment’ algorithm, melancholic patients
showed a significant CSF volume increase in the region of the
left Sylvian fissure surrounding the insular cortex. In addition, we
observed a significant volume decrease in the subarachnoid spaces
surrounding the medial and the lateral parietal lobe (see Figure 1
and Table 3). Conversely, we found no significant volume changes
in regional CSF volumes of melancholic patients when images
were segmented using the ‘unified segmentation’ algorithm
(between-group differences at the level of the left Sylvian fissure
Table 1. Clinical characteristics of melancholic patients.
Age at onset of MDD, years; mean 6 SD (range) 51.11612.57 (17–78)
Number of previous depressive episodes; mean 6 SD (range) 3.0764.13 (1–27)
Duration of Illness, years; mean 6 SD (range) 10.45610.08 (0–40)
Time to remission, days; mean 6 SD (range) 58.48646.82 (8–180)
Treatment duration at inclusion, days; mean 6 SD (range) 999.3961355.76 (0–7300)
HAM-D 17 at admission; mean 6 SD (range) 28.6067.63 (18–51)
HAM-D 17 percentage of reduction at discharge; mean 6 SD (range) 85.52613.12 (30–100)
Treatment status (.4weeks) at time of MRI; n (%)
Medication-Free 20 (28.6)
Imipramine 17 (24.3)
SSRI 10 (14.3)
Venlafaxine 3 (4.3)
Clomipramine 2 (2.9)
Imipramine with Others 7 (10)
SSRI with Others 1 (1.4)
Clomipramine with Others 2 (2.9)
Other antidepressants 8 (11.4)
HAM-D, Hamilton Rating Scale for Depression (17 items); MDD, Major Depressive Disorder; MRI, Magnetic Resonance Imaging; SSRI, Serotonin Selective Reuptake
Inhibitors.
doi:10.1371/journal.pone.0038299.t001
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were also detected in terms of a volume increase in melancholic
patients, although results were non-significant at the corrected
significance threshold: t = 3.51; pFWE= 0.134).
Validation of Voxel-wise Findings with a ROI Approach
To validate our voxel-wise findings, between-group differences
in the region of the Sylvian fissure were studied with a ROI
approach. This region constitutes an anatomically defined area
that may be reliably traced in non-segmented T1 images in
native space. The area selected for this analysis is presented in
Figure 2 overlaid onto a normalized brain, although for our
purposes tracing was performed on individual non-normalized
images. Melancholic patients showed lower mean signal in-
tensity across both left and right hemisphere ROIs, which may
be interpreted as patients having wider subarachnoidal spaces,
resulting in T1 signal intensity from (hypointense) CSF being
less affected by partial volume effects from (hyperintense)
surrounding gray matter tissue. Likewise, the left hemisphere
ROI was larger in melancholic patients, although this was not
observed for the right hemisphere region. These results are
presented in Table 4.
Table 2. Global CSF and Total Intracranial volume in melancholic patients and healthy controls assessed with the different
segmentation algorithms.
Melancholic patients Healthy controls
Between-group
Differences
Mean 6 SD (ml) Mean 6 SD (ml) t p
Global CSF volume New segment 291.50636.50 279.60636.94 1.638 0.104
Unified segmentation 477.266144.65 406.206137.76 2.555 0.012
Total Intracranial volume New segment 1396.076141.55 1370.746135.01 0.930 0.355
Unified segmentation 1530.376213.48 1454.236176.42 1.912 0.058
ml: Milliliters; SD: Standard Deviation.
doi:10.1371/journal.pone.0038299.t002
Figure 1. CSF volume alterations in melancholic patients observed using the ‘New Segment’ algorithm. Upper row. Left Sylvian fissure
CSF increases in melancholic patients. Lower row. CSF volume decreases in spaces surrounding the medial and lateral parietal cortices. Voxels with
p,0.001 (uncorrected) are overlaid on the study specific DARTEL template. x and z denote coordinates in DARTEL-template space. The color bar
represents t value. R indicates right hemisphere.
doi:10.1371/journal.pone.0038299.g001
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Clinical Correlations
Within the patient group, we correlated CSF volumes from the
regions with significant between-group differences in the above
analyses with the clinical data. In these analyses a Bonferroni
corrected significance threshold was used. Specifically, the
threshold was set at p,0.0042 (0.05/12), since we correlated the
volume of three different clusters with four clinical variables. CSF
volume at the left Sylvian fissure showed a significant negative
correlation with the percentage of HAM-D reduction between
admission and discharge (r =20.36; n= 70; p = 0.0040). The same
region was also correlated with time to symptom remission after
treatment initiation, although this finding was not statistically
significant at the Bonferroni corrected significance threshold
(r = 0.31; n = 70; p= 0.010). The number of previous depressive
episodes and the HAM-D score at admission were not correlated
with CSF volume at the left Sylvian fissure. Likewise, CSF volumes
surrounding the medial and lateral parietal regions were not
correlated with any of the clinical variables assessed.
Finally, in order to assess any medication effects on our results,
the number of days of antidepressive treatment at inclusion was
correlated against CSF volumes at the regions where between-
group differences had been detected in the above analyses, but no
significant correlations were found.
Discussion
To our knowledge, this is the first whole-brain voxel-wise study
comparing CSF volumes of melancholic patients with healthy
controls. Specifically, we observed a significant CSF increase in the
region of the left Sylvian fissure and a CSF volume decrease at the
level of the medial and lateral parietal cortex. We also observed
that such findings were not detected using earlier segmentation
algorithms. By contrast, we validated the left Sylvian fissure
alterations by means of a non-automated ROI analysis. Finally, we
detected that CSF content in the region of the left Sylvian fissure
was inversely related to clinical improvement (i.e., percentage of
HAM-D reduction between admission and discharge), which
provided our findings with clinical significance.
CSF volume increases in the left Sylvian fissure have been
previously reported in other studies with samples of depressive
Table 3. CSF coordinates of between-group differences using the ‘New Segment’ approach.
Peak coordinate
(x,y,z)* t value p value**
Number of
voxels Anatomical location
Patients.Controls 242 26 1 4.46 0.008 18 Left Sylvian fissure
Controls.Patients 8 266 57 4.87 0.002 63 Interhemispheric (medial parietal lobe)
39 254 56 4.36 0.012 45 Right lateral parietal lobe
*x, y, z denote coordinates in DARTEL-template space.
**FWE corrected for multiple comparisons.
doi:10.1371/journal.pone.0038299.t003
Figure 2. Tracing of the region of the Sylvian fissure overlaid on three orthogonal projections of a normalized brain. R indicates right
hemisphere.
doi:10.1371/journal.pone.0038299.g002
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patients [10,11,26,27]. Furthermore, such a finding complements
other reports of gray [28–30] and white [31] matter volume
decreases in the insular cortex of depressive samples. More
specifically, findings reported here are in agreement with the
reduced gray matter volume in the left insular region reported for
the same sample of patients in a previous study by our group [15].
In this sense, results from previous anatomical and functional
neuroimaging studies support the idea that the insular cortex is
relevantly involved in the pathogenesis of depressive illness. Thus,
the insular cortex is closely connected to other limbic components
such as the amygdala, ventral striatum and orbitofrontal cortex
[32] and it is particularly implicated in the awareness and
representation of emotions [32–35]. Likewise, data from functional
studies in MDD patients have also shown the implication of this
area in the abnormal processing of emotions in depression [36–
39]. Interestingly, lateralization of structural abnormalities to the
left insular region has been also reported in previous studies with
melancholic samples [11,29], although the significance of such
a finding is not fully clear.
By contrast, significant volume decreases in the CSF spaces
surrounding medial and lateral parietal cortices have not been
observed in previous studies with melancholic or general de-
pressive samples, in part because this region has not been typically
evaluated in region of interest studies. There are, however, some
reports of gray matter alterations in medial and lateral parietal
areas in depressive patients, both in terms of volume reductions
[40–42] and increases [43]. Interestingly, Shah et al. [43] reported
that gray matter volume increases in the precuneus differentiated
between chronic and recovered depressive patients, suggesting that
inconsistencies between studies may be partially accounted for by
clinical differences between the assessed samples.
In addition to complementing the description of putative
structural alterations in gray and white matter, and thus providing
a more comprehensive characterization of the structural abnor-
malities associated to psychiatric conditions, the identification of
CSF abnormalities with reliable whole-brain automated ap-
proaches may assist the development of etiopathogenic hypotheses
relating to the disorders. For example, CSF alterations located in
regions with concomitant gray and/or white matter abnormalities
may fit within neurodegenerative disease models [44,45], while
larger CSF volumes without gray and/or white matter alterations
may relate to neurodevelopmental disturbances, in terms of an
abnormal gray/white matter volume increase during early de-
velopment that is normalized with aging, resulting in larger CSF
volumes in adult life, as has been proposed for schizophrenia [46].
According to the above notions, our findings relating to an
increased CSF content in the left insular region of melancholic
patients, in combination with earlier reports of brain parenchyma
reductions in the same region [15,28–31], may be interpreted as
neurodegenerative in nature [45]. Conversely, however, the
parietal CSF volume reductions reported here are unlikely to be
of neurodegenerative origin. Nevertheless, if we consider de-
pression as a chronic and recurrent disease with multiple genetic
and environmental determinants [47–49], complex models are
plausible, and thus structural abnormalities of neurodegenerative
origin may well coexist with alterations of another etiology across
different brain areas over the course of the illness [15,44,45].
In addition to the above ideas, the CSF alterations reported
here seem to be of clinical relevance as, in our sample of
melancholic patients, larger CSF volumes in the left Sylvian fissure
were related to a smaller improvement of depressive symptom-
atology at discharge. This observation is in accordance with
previous correlations obtained with closely related measures, such
as regional CSF insular volume [10] or gray matter content of the
insular cortex [15], which were related to the time to remission of
the depressive episode after treatment initiation. Indeed, we also
observed a correlation between CSF volume increase and time to
remission, although the result was no longer significant after
Bonferroni correction for multiple comparisons. Furthermore,
there is also functional evidence supporting the relationship
between insular cortex and clinical outcome, such as the
observations of a normalization of insular hyperactivity after
clinical recovery [39] or successful antidepressant treatment
[50,51]. All in all, such results seem to indicate that the volume
of the left insular region may be a relevant predictor of symptom
persistence and response to treatment in melancholic depression.
Contrasting the results obtained with the two different image
segmentation strategies used here, we observed that the CSF
content of the left Sylvian fissure was only significantly increased
when data were pre-processed using the ‘new segment’ algorithm.
Although there is no ‘gold-standard’ for comparing the results
obtained with the two pre-processing approaches, we validated the
left Sylvian fissure CSF volume increase detected here under the
‘new segment’ approach with a non-automated ROI analysis. Left,
but not right, Sylvian fissure showed a lower mean signal intensity
in combination with a larger volume. Also, such a finding is in
accordance with earlier studies reporting brain structural altera-
tions in melancholia also using non-automated image analysis
techniques [10,11]. Furthermore, the same CSF increase was also
detected using the ‘unified segmentation’ algorithm, albeit at
a non-significant level, suggesting a reduced sensitivity of the latter
approach to detect regional changes in CSF volume. Parietal CSF
volume decreases were also uniquely detected using the ‘new
segment’ approach, although, in this case, we did not attempt to
replicate the findings with a non-automated ROI approach since
findings were located in less definite regions in anatomical terms.
Table 4. Between-group comparison of mean signal intensity and total volume for left and right Sylvian fissure (ROI analysis).
Melancholic patients Healthy controls
Between-group
Differences
Mean 6 SD Mean 6 SD t p
Mean signal intensity
(arbitrary units)
Left 309.90628.52 335.84627.97 4.621 0.000
Right 307.53627.02 328.29629.62 3.743 0.000
ROI volume (ml) Left 22.3463.32 21.1062.36 2.080 0.040
Right 20.5462.75 19.7662.29 1.531 0.129
ml: Milliliters; SD: Standard Deviation.
doi:10.1371/journal.pone.0038299.t004
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Global CSF measurements also differed between the two
segmentation methods studied. While the ‘new segment’ algorithm
detected no significant between-group differences, the ‘unified
segmentation’ approach showed an increased global CSF volume
in melancholic patients. Previous reports showed inconsistent
results regarding this measurement, with some studies reporting no
changes [52–54] and others reporting significant global increases
in depressive samples [11,55–58]. Although the differences
between studies may partially rely on clinical dissimilarities
between samples (i.e., inclusion of patients with late-onset
depression [58], or with psychotic symptoms [56]), in the light of
our findings, it would seem that global CSF assessments may have
been confounded by the inclusion of non-brain tissue. Indeed, in
a recent meta-analysis, global CSF increases were not significantly
detected in depressive samples and, furthermore, such a measure-
ment was found to depend on methodological factors such as
image acquisition parameters [59].
The current study does, however, have certain limitations.
Firstly, it is possible that antidepressant treatment may have
influenced the reported volumetric measurements, although we
did not detect any significant association between our structural
measurements and antidepressive treatment time. Secondly, as
we did not recruit a sample of non-melancholic MDD patients,
our results cannot be considered exclusive to melancholic
depression. Such a comparison would be an informative addition
to the current findings. Finally, although the ‘new segment’
approach is regarded here as the most valid algorithm to
automatically segment CSF content from brain MRIs, further
comparisons with other approaches will be required to confirm
such an assumption. Nevertheless, the lack of a ‘gold-standard’
protocol for CSF content assessment may perhaps prevent us
from obtaining a definite conclusion as to the validity of the
different CSF segmentation methods. Be that as it may, voxel-
wise alterations located at left Sylvian fissure have been validated
with a non-automated ROI analysis, and, moreover, the location
of such CSF alterations is not only concordant with earlier
reports of regional alterations in the CSF spaces of melancholic
samples, but also with previous reports of gray matter alterations
in general depressive samples.
In conclusion, this is the first study to show regional (i.e., voxel-
wise) CSF volume alterations in melancholic depression using an
automated whole-brain segmentation algorithm. Such alterations
would seem to have clinical relevance, and may indeed constitute
a relevant measurement to be considered in studies seeking
imaging predictors of remission or treatment response. Moreover,
the description of CSF alterations is necessary for a complete
characterization of the neuroanatomical abnormalities of psychi-
atric conditions, which may help in the development of
etiopathogenic hypotheses relating to the disorders. Finally, we
have also shown how the characterization of such alterations may
depend on the selection of the algorithm used for the automated
segmentation of the CSF content from brain images. The results
obtained with the ‘new segment’ algorithm, validated here by
means of a non-automated ROI assessment, are in agreement with
earlier reports also using non-automated methods of CSF
segmentation and with findings from similar whole-brain auto-
mated methods used for regional gray and white matter volume
assessment.
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